InfuSystem Holdings (INFU) Non-Current Debt (2010 - 2026)
InfuSystem Holdings' (INFU) quarterly Non-Current Debt came in at $19.6 million in Q1 2026, down 31.56% YoY from $28.7 million in Q1 2025, and little changed on a QoQ basis from $19.6 million in Q4 2025.
InfuSystem Holdings (INFU) Non-Current Debt (2010 - 2026) Analysis & Trends
InfuSystem Holdings (INFU) has 17 years of Non-Current Debt data on file, last reported at $19.6 million in Q1 2026.
- Quarterly Non-Current Debt fell 31.56% year-over-year to $19.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.6 million (down 31.56% YoY) and the FY2025 annual result came in at $19.6 million, down 17.76% from the prior year.
- Non-Current Debt was little changed at $19.6 million in Q1 2026, from $19.6 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $36.4 million in Q1 2023 to a low of $19.6 million in Q4 2025.
- A 5-year average of $29.5 million and a median of $29.9 million in 2024 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2022 — Non-Current Debt increased 11.54% — and 2026, when it plunged 31.56%.
- Tracing INFU's Non-Current Debt over 5 years: stood at $33.2 million in 2022, then retreated by 12.23% to $29.1 million in 2023, then slipped by 18.0% to $23.9 million in 2024, then slipped by 17.76% to $19.6 million in 2025, then advanced by 0.11% to $19.6 million in 2026.
- The last three Non-Current Debt figures came in at $19.6 million (Q1 2026), $19.6 million (Q4 2025), and $20.9 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 29.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 14.19 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 26.17 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.92 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 598.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.09 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 7.34 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 1.65 Bn |
| 10 | InfuSystem Holdings | 244.67 Mn | 243.70 Mn | 21.41 Mn | 20.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 20.42 Mn |
| Mar 31, 2026 | 19.65 Mn |
| Dec 31, 2025 | 19.63 Mn |
| Sep 30, 2025 | 20.93 Mn |
| Jun 30, 2025 | 26.35 Mn |
| Mar 31, 2025 | 28.71 Mn |
| Dec 31, 2024 | 23.86 Mn |
| Sep 30, 2024 | 27.98 Mn |
| Jun 30, 2024 | 34.17 Mn |
| Mar 31, 2024 | 29.93 Mn |
| Dec 31, 2023 | 29.10 Mn |
| Sep 30, 2023 | 32.66 Mn |
| Jun 30, 2023 | 36.14 Mn |
| Mar 31, 2023 | 36.39 Mn |
| Dec 31, 2022 | 33.16 Mn |
| Sep 30, 2022 | 34.46 Mn |
| Jun 30, 2022 | 33.69 Mn |
| Mar 31, 2022 | 34.79 Mn |
| Dec 31, 2021 | 32.75 Mn |
| Sep 30, 2021 | 30.90 Mn |